Zobrazeno 1 - 10
of 112
pro vyhledávání: '"upper urinary tract carcinoma"'
Publikováno v:
BMC Urology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Purpose Robotic surgery is increasingly utilized in the treatment of urothelial carcinoma of the upper urinary tract (UTUC). This study investigates the advantages and burden of robot-assisted surgical treatment of the urothelial carcinoma o
Externí odkaz:
https://doaj.org/article/deed21b878ec45f4b9c18159a8c30d9a
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionPlatinum-based chemotherapy followed by the immune checkpoint inhibitor avelumab represents an intensified upfront therapy regimen that may result in significant downstaging and, subsequently, potentially radical robotic nephroureterectom
Externí odkaz:
https://doaj.org/article/1906c4f3bdb54cb7946a47093ec48f5d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundVery few studies have been published on the causes of death of upper tract urothelial carcinoma (UTUC). We sought to explore the mortality patterns of contemporary UTUC survivors.MethodsWe performed a retrospective cohort study involving pa
Externí odkaz:
https://doaj.org/article/ca28ee0d2d204eca8cbd659d674db16b
Autor:
Hervé Lang, Claire Béraud, Luc Cabel, Jacqueline Fontugne, Myriam Lassalle, Clémentine Krucker, Florent Dufour, Clarice S. Groeneveld, Victoria Dixon, Xiangyu Meng, Aurélie Kamoun, Elodie Chapeaublanc, Aurélien De Reynies, Xavier Gamé, Pascal Rischmann, Ivan Bieche, Julien Masliah-Planchon, Romane Beaurepere, Yves Allory, Véronique Lindner, Yolande Misseri, François Radvanyi, Philippe Lluel, Isabelle Bernard-Pierrot, Thierry Massfelder
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundMuscle-invasive bladder cancer (MIBC) and upper urinary tract urothelial carcinoma (UTUC) are molecularly heterogeneous. Despite chemotherapies, immunotherapies, or anti-fibroblast growth factor receptor (FGFR) treatments, these tumors are
Externí odkaz:
https://doaj.org/article/530d7616638a4e26a742ecd5e89e062d
Autor:
Takashi Yoshida, Takashi Murota, Tomoaki Matsuzaki, Kazuyoshi Nakao, Chisato Ohe, Tadashi Matsuda, Hidefumi Kinoshita
Publikováno v:
European Urology Open Science, Vol 28, Iss , Pp 17-25 (2021)
Background: Although ureteroscopic surgery (URS) is beneficial for low-risk upper urinary tract carcinoma (UTUC), there is no standardized URS technique or navigation system for challenging cases. Objective: To present a URS technique for UTUC using
Externí odkaz:
https://doaj.org/article/b1de1c32879f49989d037bc11a43d74d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Andrey Soares, Icaro Carvalho, Diogo Assed Bastos, Diogo Augusto Rodrigues da Rosa, Fernando Cotait Maluf, Ary Adamy, Daher Chade, Luis Felipe Piovesan, Allisson Bruno Barcelos Borges, Arthur Accioly, Lucas Nogueira
Publikováno v:
Brazilian Journal of Oncology, Vol 16, Iss (2020)
Urothelial carcinoma is a frequent worldwide malignancy. Poor survival rates in muscle-invasive and metastatic urothelial carcinoma impose major challenges for management. We conducted a consensus meeting to discuss the optimal treatment for urotheli
Externí odkaz:
https://doaj.org/article/bbe38035dcda4e90bd7a94891a8f97c9
Publikováno v:
Research and Reports in Urology, Vol Volume 10, Pp 251-261 (2018)
Makito Miyake, Takuya Owari, Shunta Hori, Yasushi Nakai, Kiyohide Fujimoto Department of Urology, Nara Medical University, Kashihara-shi, Nara 634-8522, Japan Abstract: Urothelial carcinoma (UC) arises extensively from the renal pelvis, ureter, urina
Externí odkaz:
https://doaj.org/article/62352b5fffdc4c698e4efe015d4588a9
Autor:
Yu Miyama, Teppei Morikawa, Jimpei Miyakawa, Yuichi Koyama, Taketo Kawai, Haruki Kume, Masashi Fukayama
Publikováno v:
Cancer Medicine, Vol 7, Iss 9, Pp 4330-4338 (2018)
Abstract Programmed cell death ligand‐1 (PD‐L1) is a ligand for programmed cell death‐1 (PD‐1) that negatively regulates T‐cell activation and plays a crucial role in suppressing anti‐tumor host immunity. Although PD‐L1 is a promising i
Externí odkaz:
https://doaj.org/article/ed5a8ca77930448ea95bdce11fcf3af8